We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Machine Learning Solution Assists Pathologists in Detection of Precancerous Cervical Lesions

By LabMedica International staff writers
Posted on 15 Jun 2023
Print article
Image: A machine learning solution assists pathologists in detection of cervical dysplasia (Photo courtesy of Freepik)
Image: A machine learning solution assists pathologists in detection of cervical dysplasia (Photo courtesy of Freepik)

Cervical cancer ranks as the fourth most prevalent cancer in women, with a reported 604,000 new occurrences in 2020, as per the World Health Organization (WHO). Yet, it stands out as one of the most successfully preventable and treatable cancers, provided that it is detected early and managed appropriately. Therefore, early detection of pre-cancerous lesions is critical for disease prevention. Now, researchers have developed an innovative method using large, high-resolution images to detect crucial pre-cancerous lesions.

A team of researchers from INESC TEC (Porto, Portugal) and IMP Diagnostics (Porto, Portugal) has designed a machine learning solution to aid pathologists in detecting cervical dysplasia, making the diagnosis process of new samples fully automatic. This is among the first published works to utilize complete slides. The researchers set out to develop machine learning models to support the subjective classification of lesions in the squamous epithelium - the protective tissue layer against microorganisms - using whole-slide images (WSI) that contain information from the entire tissue.

The team developed a weakly-supervised methodology - a machine learning method that combines annotated and non-annotated data in the model training phase to classify cervical dysplasia. This technique proves particularly beneficial considering the difficulty of obtaining pathology data annotations: the large image sizes make the annotation process extremely time-consuming, tedious, and highly subjective. This methodology enables researchers to establish models with high performance, even when there's some missing information during the training phase. The resulting model can then grade cervical dysplasia, or abnormal cell growth on the surface, as low (LSIL) or high-grade intraepithelial squamous lesions (HSIL). Given the complexity and subjective nature of the classification process, these machine learning models can provide valuable assistance to pathologists. Furthermore, these systems could act as an early warning mechanism for suspicious cases, alerting pathologists to instances that warrant closer examination.

"In the detection of cervical dysplasia, this was one of the first published works that use the full slides, following an approach that includes the segmentation and subsequent classification of the areas of interest, making the diagnosis of new samples completely automatic," explained Sara Oliveira, a researcher at INESC TEC.

Related Links:
INESC TEC 
IMP Diagnostics 

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
Benchtop Cooler
PCR-Cooler & PCR-Rack

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.